• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA launches new priority review voucher program for select biopharmas

Adagio Therapeutics

change direction new plan alter arrows move reprioritize
Biotech

Invivyd evolves yet again to keep pace with COVID-19

Invivyd, launched in the early days of the pandemic as Adagio to find treatments for COVID-19, is hoping the third monoclonal antibody is the charm.
Annalee Armstrong Mar 6, 2023 10:45am
Layoffs

Invivyd faces C-suite departures, commercial layoffs

Oct 14, 2022 10:29am
image of a few paragliders

Catalent shakes up leadership, taps new CEO—Chutes & Ladders

Jul 8, 2022 9:30am
CEO chair executive leadership

Adagio selects permanent CEO after founding leader's resignation

Jul 5, 2022 11:17am
Resist resistance fight against cancer arrows out tumor immunotherapy

Adagio still hopes to build omicron offense for COVID-19 therapy

May 13, 2022 10:31am
venture capital funding

Biotech's top 10 money raisers of 2021

Apr 18, 2022 3:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings